微管不稳定与血小板产量在终端分化hiPSC衍生的巨核细胞系中的关联
Emiri Nakamura1, Yasuo Harada1, Trevor Bingham2
1Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
PloS one
|June 25, 2025
概括
科学家们发现,像温克里斯这样的微管不稳定剂可以增加干细胞的血小板生产. 这些实验室培养的血小板具有功能,可以提供可靠的输血来源,克服捐赠血小板的短缺.
科学领域:
- 生物技术是生物技术.
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
背景情况:
- 捐献的血小板有局限性,包括短暂的保质期,供应短缺和免疫不相容性.
- 人类诱导的多能干细胞 (hiPSC) 衍生的巨核细胞 (MKs) 为产生通用供体血小板提供了一个潜在的解决方案.
- 从可扩展的hiPSC衍生的巨核细胞细胞系 (imMKCLs) 生产血小板的现有方法显示异质和异步成熟.
研究的目的:
- 确定方法来提高ImMKCLs的血小板生产效率.
- 研究微管力学在巨核细胞成熟和血小板生产中的作用.
- 为了评估从imMKCLs获得的血小板的功能,这些血小板被用微管不稳定剂治疗.
主要方法:
- 单细胞时间过程成像分析imMKCL成熟.
- 化学查以确定增强血小板生产的药物.
- 用微管 (MT) 破坏稳定剂治疗imMKCLs,包括温克里斯 (VCR).
- 通过激素反应,粘附,扩散和体内静血测试来评估血小板功能.
- 静态培养中的血小板产量与流优化生物反应器 (VerMESTM) 的比较.
主要成果:
- 温克里斯 (VCR) 治疗促进血小板扩张,并通过破坏微管的稳定,增加每imMKCL的血小板产量.
- 由VCR诱导的血小板表现出减少的外周微管体含量,但保持正常功能,包括激素反应,粘附,扩散和体内静血.
- 在imMKCL微管含量和血小板产量之间存在负相关性,较低的MT含量 (在VerMESTM生物反应器中实现) 导致更高的产量.
- 在静态培养下,imMKCL的成熟是异质的和异步的,限制了血小板生产效率.
结论:
- 微管的动态对于调节巨核细胞的成熟和血小板的产生至关重要.
- 温克里斯和优化的生物反应器条件可以显著提高功能性hiPSC衍生的血小板的产量.
- 这些发现有助于开发一种负担得起的,现成的通用捐赠血小板来源,解决临床关键需求.
- 这项研究为观察到的与 in vivo vinca 类化合物使用相关的血栓细胞形成提供了潜在的解释.
相关概念视频
Destabilization of Microtubules
2.8K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K
Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Microtubule Instability
5.3K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.3K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


